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Abstract
Background: Environmental Enteropathy (EE) is a subclinical condition caused by constant fecal-oral contamination
and resulting in blunting of intestinal villi and intestinal inflammation. Of primary interest in the clinical research is to
evaluate the association between non-invasive EE biomarkers and malnutrition in a cohort of Bangladeshi children.
The challenges are that the number of biomarkers/covariates is relatively large, and some of them are highly correlated.
Methods: Many variable selection methods are available in the literature, but which are most appropriate for EE
biomarker selection remains unclear. In this study, different variable selection approaches were applied and the
performance of these methods was assessed numerically through simulation studies, assuming the correlations
among covariates were similar to those in the Bangladesh cohort. The suggested methods from simulations were
applied to the Bangladesh cohort to select the most relevant biomarkers for the growth response, and bootstrapping
methods were used to evaluate the consistency of selection results.
Results: Through simulation studies, SCAD (Smoothly Clipped Absolute Deviation), Adaptive LASSO (Least Absolute
Shrinkage and Selection Operator) and MCP (Minimax Concave Penalty) are the suggested variable selection
methods, compared to traditional stepwise regression method. In the Bangladesh data, predictors such as mother
weight, height-for-age z-score (HAZ) at week 18, and inflammation markers (Myeloperoxidase (MPO) at week 12 and
soluable CD14 at week 18) are informative biomarkers associated with children’s growth.
Conclusions: Penalized linear regression methods are plausible alternatives to traditional variable selection methods,
and the suggested methods are applicable to other biomedical studies. The selected early-stage biomarkers offer a
potential explanation for the burden of malnutrition problems in low-income countries, allow early identification of
infants at risk, and suggest pathways for intervention.
Trial registration: This study was retrospectively registered with ClinicalTrials.gov, number NCT01375647, on
June 3, 2011.
Keywords: Biomarker selection, Penalized linear regression, Correlated covariates, Malnutrition, Environmental
enteropathy
*Correspondence: jzm4h@virginia.edu
5Division of Biostatistics, Department of Public Health Sciences, University of
Virginia, Charlottesville, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lu et al. Biomarker Research  (2017) 5:9 Page 2 of 10
Background
High dimensional data analysis has become common and
important in biomedical studies. For example, tens of
thousands of molecular expressions are potential predic-
tors in microarray data; hundreds of thousands of single
nucleotide polymorphisms (SNPs) are possibly associated
with the clinical outcome of interest in genome-wide asso-
ciation study [1]. To deal with large number of covariates
or predictors, one common approach is testing the associ-
ation between each covariate and the outcome of interest
through univariate regression model; a subset of those
covariates are then selected based on their significance
for subsequent multivariable analysis. This framework
is a common method in biomedicine for variable selec-
tion, but it can be a great challenge when the number
of covariates is large in massive datasets. Also, predic-
tion accuracy and interpretability are twomain drawbacks
for this traditional regression analysis [2]. Another widely
used method in variable selection is regression with step-
wise selection, where the choice of predictive variables
is carried out by an automatic procedure. However, the
essential problems with such method remain, that is, the
parameter estimates tend to be highly biased in absolute
values, their standard errors tend to be incorrect, and p-
values tend to be too low due to multiple comparisons and
are difficult to correct [3].
Penalized regression methods such as LASSO (Least
Absolute Shrinkage and Selection Operator [4]) and
SCAD (Smoothly Clipped Absolute Deviation [5]) have
been developed to overcome the limitation of tradi-
tional variable selection methods when the number of
covariates is large. However, these penalized regression
methods remain less familiar to biomedical researchers,
but start to gain more attentions in clinical applications
[6–10]. In this study, we reviewed several penalized lin-
ear regression methods along with the regression method
with stepwise selection, presented some common tuning
parameter selection criteria, and compared their numer-
ical performance through a simulation study which has
similar setting as our motivating clinical example.
Our study was motivated by the data from a birth
cohort study, the PROVIDE (Performance of Rotavirus
and Oral Polio Vaccines in Developing Countries) study.
The PROVIDE study was aimed at investigating oral vac-
cine efficacy and the impact of environmental enteropathy
(EE) on vaccine failure and malnutrition in Bangladesh
children. EE, also known as tropical enteropathy or envi-
ronmental enteric dysfunction, is a subclinical condition
or gut disorder caused by constant fecal-oral contamina-
tion and resulting in blunting of intestinal villi and intesti-
nal inflammation [11]. EE is prevalent among inhabitants
of low-income countries living in environments with poor
sanitation and hygiene, where diarrhea and respiratory
infections are the leading causes of death in children
under age 5. However, both non-invasive tests and effec-
tive interventions for EE are lacking [12]. In the PROVIDE
study, a large and comprehensive set of non-invasive
biomarkers were developed from fecal and blood sam-
ples that were collected surrounding the time of vacci-
nation, and some of them were highly correlated. One of
the primary study interests was to identify non-invasive
EE biomarkers associated with malnutrition and vaccine
responses. By investigating the association of these earlier
risk factors and biomarkers with child growth, effective
intervention strategies for malnutrition can be developed.
There are two main challenges in the PROVIDE study:
the relatively large number of biomarkers or covariates
and the strong correlation among these biomarkers. To
overcome these challenges in practice, we prefer to use
the penalized linear regression models for the biomarker
selection. However, given many variable selection meth-
ods available in the literature, which are most appropriate
for EE biomarker selection remains unclear. Our objec-
tive was to assess the performance of different penalized
linear regression methods numerically through a simu-
lation study under different variable selection scenarios.
The suggested methods from simulations were applied to
the PROVIDE study cohort.
Methods
In this section, we first describe the PROVIDE study
and the data collection. Then, we introduce the penal-
ized linear regression models along with their pros and
cons. Next we specify the simulation setting to com-
pare penalized models. Finally, we describe the methods
for biomarker data analysis. The simulation results and
the biomarker data analysis results are presented in the
Results section.
Data description
The study design, recruitment and follow-up of the
PROVIDE cohort were described previously [13]. Briefly,
a birth cohort of 700 infants from the Mirpur urban slum
in Dhaka, Bangladesh were enrolled and followed for 2
years. The PROVIDE study was a randomized controlled
clinical trial with a 2-by-2 factorial design to investigate
the efficacy of Rotavirus and Oral Polio Vaccines. During
the first 2 years of life, children were monitored through
twice weekly household visits by field research assistants
and regularly scheduled clinical visits. There was rolling
admission of subjects over the first 18 months and the
study spanned fromMay 2011 to November 2014. A com-
prehensive set of biomarkers were developed from fecal,
urine and blood samples that were collected at week 6, 12,
18 and 24 of age. The study was approved by the Ethical
Review Board of the ICDDR,B (FWA 00001468) and the
Institutional Review Boards of the University of Virginia
(FWA 00006183).
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The height-for-age z-score (HAZ) at one year old was
the outcome of interest in this study. HAZ is an age-
and gender-normalized measure of child height using the
world health organization (WHO) Multicenter Growth
Reference Study Child Growth Standards. HAZ has been
considered as the most important measurement for mal-
nutrition in the literature as it captures the long-term
cumulative effects of health throughout the childhood and
is known to be correlated with later life outcomes [14, 15].
Our interest was to evaluate and identify the significant
effects of these earlier risk factors and biomarkers on the
child growth. We hypothesized that early infant intesti-
nal and systemic biomarkers, as well as socioeconomic
status (SES), nutritional measures, and maternal factors,
were significantly associated with HAZ at one year old. All
together, a total of 33 biomarkers and clinical risk factors
were available, and their descriptive statistics (means and
standard deviations) were summarized in Table 1. Note
that those listed under the enteric inflammation category
were considered to be the EE biomarkers, which were of
particular interest. A key challenge in the clinical study
was how to identify the informative biomarkers associated
Table 1 Biomarker list and descriptive summary in PROVIDE study (N = 512)
Variable category Biomarker Child age (week) Mean (SD)
Enteric inflammation Myeloperoxidase (MPO) 12 10952.92 (11489.08)
Calprotectin 12 781.68 (725.30)
Neopterin 12 2601.90 (2041.17)







Days of diarrhea 18 6.22 (10.75)
Systemic inflammation Ferritin 6 229.42 (153.31)
18 45.45 (56.39)

















Retinol binding protein (RBP)
6 24317.52 (11461.94)
18 29780.83 (15167.70)
Height for age z score (HAZ)
Birth -0.90 (0.89)
18 -1.02 (0.93)
Weight for age z score (WAZ) 18 -0.82 (1.06)
Weight for height z score (WHZ) 18 -0.10 (1.01)
Days of exclusive breast milk feeding 18 95.99 (41.71)
Maternal health, SES Monthly household expenditure NA 11736.56 (7555.13)
Monthly household income NA 13021.23 (9708.96)
Mother height (cm) NA 150.38 (5.61)
Mother weight (kg) NA 49.36 (9.33)
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with HAZ. Nevertheless, some of these biomarkers were
highly correlated, presenting an extra challenge to the data
analysis.
Penalized linear regression
To select informative biomarkers and risk factors from
33 available predictors that are associated with HAZ at
one year old, traditional methods (univariate regression
or stepwise regression) have drawbacks as described in
the Background. In practice, since only a small number of
factors are truly informative with respect to the response
of interest, univariate or multivariable regression analyses
could produce biased or false-positive results. In addition,
identifying important biomarkers in this case may partic-
ularly be challenging because some factors were strongly
correlated (Fig. 1). In the PROVIDE data, eight predic-
tors were highly correlated, including monthly household
expenditure (exp), income, mother weight, mother height,
weight-for-age z-score (WAZ) at week 18, weight-for-
height z-score (WHZ) at week 18, HAZ at birth and
week 18. In Fig. 1, the heat map of correlation matrix
(ordered by correlation coefficients) is plotted. It would
be reasonable to assume the correlation structure among
these 8 predictors to be autoregressive with order 1 (i.e.,
AR(1)) and the other 25 covariates to be independent.
We were interested in identifying appropriate variable
selection methods that can perform well when some of
the covariates are highly correlated as in the motivating
example.
Consider the linear regression model
Y = Xβ + , (1)
where Y is an n×1 vector and X is an n×pmatrix. Linear
regression is a widely used method to study association
between continuous outcome and covariates. In the pres-
ence of multiple covariates or predictors, univariate lin-
ear regression followed by multivariable linear regression
with thresholding p-values is the conventional approach
in biomedical research. However, given the drawbacks in
the traditional approach as discussed in the Background,
penalized regression methods have become popular and
better alternatives to select variables and estimate regres-
sion parameters simultaneously. The regression param-
eters are assumed to be sparse with some components
being zero, while the nonzero components are for the
informative variables. Penalized methods shrink the esti-
mates of regression coefficients towards zero relative to







































































































































































































Fig. 1 Heatmap of correlation for all biomarkers
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A form of the penalized least squares estimator is the







where β = (β1, ...,βp) and pj(| · |), is the penalty func-
tion, which takes different forms for different methods.
The first part of the objective function is the sum of
least squares errors, measuring the model goodness of
fit. The second part is penalty term, representing model
complexity. Specifically, different penalized linear regres-
sion models with their pros/cons are summarized in the
following.
• LASSO: The L1 penalty, i.e., pj(|θ |) = λ|θ |,
corresponds to the LASSO estimator [4]. Applying
the L1 penalty tends to result in many regression
coefficients shrunk exactly to zero and a few other
regression coefficients with comparatively little
shrinkage. If the pairwise correlation among variables
are very high, LASSO tends to select only one
variable from the group.
• Elastic Net: The L2 penalty pj(|θ |) = λ|θ |2 leads to a
ridge regression, which tends to result in all small but
nonzero regression coefficients. A linear combination
of L1 and L2 penalties is Elastic Net. It enjoys a
similar sparsity of representation as LASSO, while
encouraging a grouping effect [16].




I(θ ≤ λ) + (aλ−θ)+
(a−1)λ I(θ > λ)
}
, for some
a > 2 and θ > 0, is the SCAD penalty [5], where
pλ(0) = 0 and a ≈ 3.7 as suggested by Bayesian risk
analysis.
• MCP: The Minimax Concave Penalty [17] is defined
as p′λ(θ) = (aλ−θ)+a , which translates the flat part of
the derivative of SCAD to the origin.
• Adaptive LASSO: a weighting scheme wj = |β˜j|−γ for




Though the penalties above quantify the model com-
plexity differently, they all aim to strike a balance between
model goodness of fit and model simplicity, and promote
sparse estimates of the regression parameters, where the
sparsity indicates variable selection. It is shown in the
literature that, SCAD, MCP and Adaptive LASSO enjoy
the so-called Oracle properties, compared with LASSO
and Elastic Net [1]. That is, SCAD, MCP and Adaptive
LASSO select the true model consistently and estimate
the nonzero parameters with the asymptotic distribution
as if the true model were given.
An important issue in variable selection is to deter-
mine the optimal value for tuning parameter λ, as its
value regulates how many variables are to be selected
in practice. When λ = 0, all variables are selected.
When λ = ∞, and if the penalty function satisfies
limλ→∞ pλ(|θ |) = ∞ for θ = 0, none of the variables
is selected. There are various criteria to select tuning
parameter, including Mallow Cp [19], Akaike Informa-
tion Criterion (AIC) [20], Bayesian Information Criterion
(BIC) [21], Generalized Cross-Validation (GCV) [22] and
Cross Validation (CV) [2]. Wang et al. showed that the
penalized estimator with BIC criterion for selecting tun-
ing parameter achieves the model selection consistency
and the Oracle properties [23]. Based on their sugges-
tion, we chose the BIC criterion for all the methods in
numerical studies. For Elastic Net, we used grid search for
both the proportion (α) of L1 and L2 penalty and tuning
parameter.
Simulation setup
Simulation studies were designed to assess the relative
performance of the different penalized linear regression
methods in variable selection with respect to correlation
structure and signal-to-noise ratio (SNR). SNR is defined
as the ratio of signal power to the noise power, calculated
as variance of linear combination of predictors (signal)
divided by variance of error (noise). The datasets in the
simulation were generated with 500 observations and 33
correlated predictors, which are similar to the PROVIDE
cohort data. Also, the coefficients in the simulated models
were specified similarly as the estimates from the real
data. The traditional linear regression was applied with
p-value < 0.05 as the threshold for the univariate selec-
tion of biomarkers. Seven covariates (HAZ at week 18,
days of exclusive breast milk feeding until week 18, ferritin
at week 6, mannitol in urine at week 12, Myeloperoxi-
dase (MPO) at week 12, mother weight and soluble CD14
at week 18) were informative and selected for the out-
come. In simulation, 7 out of 33 covariates were assumed
to be nonzero. Based on the real data, the correlation
structure within the first eight covariates was assumed as
AR(1) with ρ = 0.5, and as independent for the remain-
ing 25 covariates. We generated 100 simulation datasets
from a multivariate normal distribution with mean zero
and marginal variance one in the covariance matrix as
specified above. To explore the influence of weak/strong
correlation and SNR, we further varied ρ = 0.2, 0.5, 0.8
and SNR=1, 3, 5.
The key criterion for comparing the performance of
different methods is the median relative model error
(MRME), as suggested in [5]. For an estimator θˆ of θ , the
model error is defined by ME(θˆ ) = (θˆ − θ)′	(θˆ − θ),
where	 denotes the covariancematrix of the correspond-
ing regressors. Then the relative model error (RME) is
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calculated by ME(θˆ )/ME(θˆLS), with θˆLS denotes the least
squares estimator of the overall model. The Oracle esti-
mator is the least squares estimator of the true model.
Thus, the RME for the Oracle estimator is calculated by
ME(θˆLST )/ME(θˆLS), with θˆLST denotes the least squares
estimator of the true model. The MRME is the median of
relative model errors.
True positive (TP) and false positive (FP) provide dif-
ferent perspectives of the performance measure for model
comparison. For a given simulated dataset, a variable is
selected if its estimated coefficient is nonzero. TP is the
average number of nonzero covariates being correctly
selected, and FP is the average number of zero covariates
being incorrectly selected.
Biomarker data analysis
Environmental enteropathy is a subclinical enteric condi-
tion found in low-income countries that is characterized
by intestinal inflammation, reduced intestinal absorption,
and gut barrier dysfunction. Among all the biomarkers
and risk factors in Table 1, we aimed to identify the
important subset associated with HAZ at one year in the
PROVIDE study birth cohort.
Given a few dozen of available biomarkers as the poten-
tial predictors, traditional variable selectionmethods such
as stepwise regression were not practical or less efficient.
Modern penalized linear regression methods reviewed
earlier can effectively identify the subset of biomarkers
that are truly informative to the response of interest.
Based on the relative performance of these penalized
regression methods from numerical simulations and the
degree of correlations among the biomarkers, the sug-
gested methods were applied to the PROVIDE biomarker
data to identify the important biomarkers. We also evalu-
ated the validity of methods through bootstrap sampling,
and estimated the percentage of times being selected for
each biomarker. Similar subsampling/bootstrapping idea
can also be found in [24, 25]. For comparison purpose, the
traditional stepwise regression method was also applied
to the biomarker data. All the data analyses and sim-




Table 2 summarizes the MRME, TP and FP by different
penalized methods over 100 simulated datasets. When
the SNR was low (SNR=1), the SCAD penalty performed
the best for all three correlation levels (ρ) in the simu-
lation setting. The results of SCAD had relatively larger
true negative rates, along with relatively smaller FP, result-
ing in the smallest MRME (43.51% for ρ = 0.2, 43.00%
for ρ = 0.5 and 42.13% for ρ = 0.8). The MRMEs
of SCAD were closest to the Oracle estimator compared
to other methods. Comparatively, Adaptive LASSO and
MCP performed relatively well, having the second and
third smallest MRME. Though Elastic Net and Stepwise
had relatively large TP, they also had largest FP. When
SNR was increased to 3, however, Adaptive LASSO per-
formed the best for all the three ρ values with the smallest
MRME (54.50% for ρ = 0.2, 56.64% for ρ = 0.5 and
56.21% for ρ = 0.8). MCP and SCAD followed as the
second and third, with reasonable large TP and small FP.
Elastic Net and Stepwise methods again yielded large FP.
Finally, when SNR was increased to 5, Elastic Net and
LASSO performed less satisfactory. When the correlation
was moderate (ρ = 0.2, 0.5), Stepwise did slightly better
than Adaptive LASSO andMCP, but when correlation was
large (ρ = 0.8), Adaptive LASSO performed better than
Stepwise and MCP. In most of the cases, stepwise had the
smallest FP, but its TP was also relatively low. In the case
of correlated variables, stepwise tended to select less for
both zero and nonzero variables.
In summary, the numerical performance of different
variable selection methods in this simulation setting
depended on both the strength of correlation among
covariates and SNR.When SNR was low, SCAD, Adaptive
LASSO and MCP were preferred; when SNR was large,
Adaptive LASSO, stepwise and MCP performed similarly,
regardless of the low/high correlation. The correlation
structure in our simulations is quite common in prac-
tice, where some variables are independent while other
variables are correlated.
Environmental enteropathy biomarker analysis
We applied both traditional and suggested penalized
regression methods from simulations to the biomarker
data in the PROVIDE study. A total of 512 children
with all 33 biomarkers available were included in this
biomarker data analysis. HAZ at one year of age was
the outcome of interest, with mean ± SD as −1.47 ±
1.02. The SNR was estimated at 2.6 in the linear model
from our data, and the correlation structure among the
first eight covariates as AR(1) with ρ = 0.5. As sug-
gested by the simulation, Adaptive LASSO, MCP and
SCAD would be preferred, while Elastic Net and Step-
wise methods performed less satisfactorily. The selection
result from real data (Table 3) confirmed this numerical
observation.
As shown in Table 3, there were 16 biomarkers cho-
sen at least once, while 17 biomarkers were not selected
by any method. Using the BIC selection criterion for
tuning parameter, 4 biomarkers were selected by the step-
wise regression, 7 by Adaptive LASSO, 8 by MCP, 9 by
SCAD, 11 by LASSO, 12 by Elastic Net. Stepwise tended
to select too few biomarkers, while LASSO and Elas-
tic Net selected too many biomarkers. The suggested
methods, Adaptive LASSO, MCP and SCAD, selected
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Table 2 Comparison of methods with different correlation levels (ρ) and signal noise ratio (SNR) from 100 simulation datasets
ρ SNR Criteria Stepwise Elastic Net LASSO MCP SCAD Adaptive LASSO Oracle
1 TP 2.30 4.44 4.48 3.78 4.26 3.74 7.00
FP 0.30 4.06 4.20 2.30 3.39 2.04 0.00
MRME (%) 60.40 46.34 46.56 45.04 43.51 45.23 17.93
0.2 3 TP 4.97 6.51 6.55 6.05 6.35 6.08 7.00
FP 0.35 4.75 4.80 2.04 3.34 2.08 0.00
MRME (%) 65.26 61.87 62.17 56.00 59.48 54.50 17.93
5 TP 6.16 6.89 6.88 6.68 6.76 6.71 7.00
FP 0.41 5.30 5.32 1.93 3.21 2.06 0.00
MRME (%) 46.40 61.05 61.65 49.76 52.87 47.44 17.93
0.5 1 TP 2.29 4.38 4.41 2.66 4.15 3.67 7.00
FP 0.34 4.16 4.11 2.38 3.36 2.17 0.00
MRME (%) 57.76 46.01 46.56 44.03 43.00 44.66 17.89
3 TP 4.95 6.54 6.54 6.01 6.31 6.00 7.00
FP 0.39 4.79 4.73 1.99 3.20 2.16 0.00
MRME (%) 65.52 60.72 62.90 56.98 60.66 56.64 17.89
5 TP 6.15 6.88 6.87 6.70 6.76 6.72 7.00
FP 0.38 5.28 5.27 1.82 3.04 2.14 0.00
MRME (%) 46.56 60.39 61.09 49.18 52.93 48.03 17.89
0.8 1 TP 2.07 4.12 4.05 3.30 3.76 3.34 7.00
FP 0.58 4.47 4.20 2.25 3.24 2.21 0.00
MRME (%) 58.85 44.01 45.63 44.16 42.13 42.63 18.04
3 TP 4.54 6.36 6.32 5.76 6.07 5.78 7.00
FP 0.52 5.16 4.88 2.03 2.90 2.37 0.00
MRME (%) 65.93 60.92 63.41 58.36 59.99 56.21 18.04
5 TP 5.90 6.85 6.83 6.51 6.61 6.59 7.00
FP 0.49 5.59 5.37 1.73 2.83 2.27 0.00
MRME (%) 52.57 59.45 62.29 53.52 56.85 50.16 18.04
Oracle estimator is the least squares estimator of the true model, which contains seven nonzero covariates. TP (True Positive) is the average number of nonzero covariates
being correctly selected. FP (False Positive) is the average number of zero covariates being incorrectly selected. Median relative model error (MRME) is used to measure the
overall performance of different models
similar sets of biomarkers in the real data analysis. As
the validity measure of variable selection methods, the
percentage of times for biomarkers being selected were
listed in parenthesis, which were obtained through 100
bootstrapping samples. The results showed that all the
selected biomarkers, except for Vitamin D at week 18,
had over 52% chance of being selected via the boot-
strapping, and some biomarkers such as HAZ at week
18 and mother weight had the selection percentages
close to 100%.
When comparing the selection results of Adaptive
LASSO, MCP and SCAD, four covariates were selected
consistently by all the three methods. Among them, HAZ
and WHZ at week 18 and mother weight were posi-
tively associated with HAZ at one year, while Mannitol
at week 12 was negatively associated with the response.
The selection results are clinically meaningful, and our
findings are similar to that in [8].
Overall, from the variable selection results, EE and sys-
temic inflammation biomarkers, and measures of mater-
nal health were informative of malnutrition. Particularly,
nutritional status (HAZ and WHZ) and RBP at week 18,
mother weight, and family expenditure were positively
associated with HAZ at one year of life, while mannitol
and MPO at week 12, and soluble CD14 at week 18 were
negatively associated with the outcome. The predictors
selected by all methods such as mother weight and HAZ
at week 18 indicate the predestination of malnutrition.
These results offer a potential explanation for the burden
of malnutrition problems in low-income countries, allow
early identification of infants at risk, and suggest pathways
for intervention.
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Table 3 Selection results by different variable selection methods
Biomarkers Variable selection methods
Stepwise Elastic Net LASSO MCP SCAD Adaptive LASSO
HAZ at birth - (0.54)
WAZ at wk18 + (1.00)
HAZ at wk18 + (0.98) + (1.00) + (1.00) + (1.00) + (1.00) + (1.00)
WHZ at wk18 + (0.70) + (1.00) + (1.00) + (1.00) + (0.74)
Exclusive breast feeding until wk18 - (0.80) - (0.73) - (0.67) - (0.77)
RBP at wk18 + (0.72) + (0.72) + (0.59) + (0.69)
Vitamin D at wk18 - (0.32)
Mannitol at wk12 - (0.73) - (0.72) - (0.60) - (0.71) - (0.96)
Mannitol at wk24 - (0.85)
ALA at wk12 + (0.62)
MPO wk12 - (0.59) - (0.87) - (0.87) - (0.80) - (0.87)
Expenditure + (0.87) + (0.87) + (0.60) + (0.75)
Mother weight + (0.89) + (1.00) + (1.00) + (0.97) + (0.99) + (0.90)
Mother height + (0.52) + (0.52)
Reg1B at wk12 - (0.58) - (0.53)
Soluble CD14 at wk18 - (0.66) - (0.67) - (0.62)
Here, “+” and “-” means positive and negative sign of coefficient estimates. Percentage of variables being selected via 100 bootstrapping samples is listed in parenthesis
Discussion
This study was motivated by the PROVIDE clinical study
to evaluate the association between early-stage non-
invasive biomarkers and future child growth. The main
challenges in practice are 1) the relatively large set of pre-
dictors, including both clinical risk factors and biomarkers
and 2) some of them are highly correlated. Through sim-
ulations of different signal-to-noise sizes and correlation
strength, we compared the numeric performance of step-
wise regression and several penalized linear regression
methods in a simulation setting similar to the clinical
data example. For the biomarker data from the PROVIDE
study, SCAD, Adaptive LASSO and MCP are recom-
mended due to their performance based on simulations,
with relatively large true positive rates, and relatively small
false positive rates. To our expectation, the selection result
of the real data confirms the observation from simula-
tions. We also explored the selection results by different
methods when the SNR and correlation are high or low via
simulations. Also, these penalized linear regression meth-
ods can be applied to generalized regression models such
as Logistic or Poisson regression.
Our study addressed an important question in the
field of international health and environmental enteropa-
thy, namely how to analyze large datasets with highly
correlated variables or predictors. Identifying the non-
invasive biomarkers associated with malnutrition is the
first step. The ultimate goal of the EE studies is to
have better understanding of underlying pathogenesis and
to facilitate the development of treatment strategies for
malnutrition. Nevertheless, our findings and suggested
methods are not only applicable to the EE studies, but also
to the other biomedical studies for biomarker selection.
In this study, we only considered the situation similar
to the clinical study where sample size is larger than vari-
able dimension (n > p). For cases that p is at the same
scale as n, or even p 	 n, Fan and Lv proposed sure
independent screening (SIS) to perform variable selection
in ultra-high dimension space [26]. The idea is to first
perform the correlation learning to reduce dimensionality
from high to a moderate scale, and then various variable
selection methods can be applied.
Statistical inference is challenging for penalized
estimators. Generically, the confidence intervals do not
exist for the parameter estimates from penalized methods
[27]. Therefore a hypothesis testing cannot be directly
established. Tibshirani proposed standard error approxi-
mation formula using the bootstrapping method [4]. Fan
and Li used sandwich formula to estimate the covariance
matrix [5]. However, the approximate covariance matrix
by their formula produced an estimated variance 0 for
non-selected predictors with βˆj = 0 [28]. The same issue
happens when residual bootstrapping is applied. The
signs of non-zero components of β are estimated correctly
with high probability, but the estimators of the zero-
components may take both positive and negative values
with positive probabilities [28]. Wasserman and Roeder
proposed a two-stage procedure for valid inference [29].
Lu et al. Biomarker Research  (2017) 5:9 Page 9 of 10
In their method, the data is randomly divided into two
parts: training and testing datasets. In the training data,
penalized linear regression is used to select informative
variables as the first stage. In the testing data, ordinary
least squares (OLS) is applied to compute standard errors
and p-values for the variables selected in the first stage.
A drawback of the single-split method is that the result
may depend on how the data is split. To improve this,
Meinshausen et al. suggested multi-split method, which
repeats the single-split multiple times, and obtains the
empirical distribution of the p-values [30]. Recently,
Lockhart et al. proposed the covariance test statistic to
test the significance of the predictor variable that enters
the current LASSO model [31]. Since it is a conditional
test, the interpretation of p-value is different; given all
active variables entering in the LASSO path previously,
the p-value is for the significance of the next variable
entering the model [32]. To our knowledge, significant
testing on selected variables methods is still an open
problem.
In summary, we assessed the numerical performance
of penalized linear regression methods through simula-
tions for correlated covariates or predictors, and further
applied the suggested methods to the selection of EE
biomarkers in a Bangladesh birth cohort. Our study was
motivated by a clinical study, and our findings are read-
ily applicable to other EE studies, or to other biomedical
studies with high-dimensional and correlated predictors,
for biomarker selection. The strengths of this study are
the practicality and applicability of our findings, that is,
the plausible application of the penalized regressionmeth-
ods to high-dimensional and correlated data. In the era
of big data, it is pivotal to decipher the large and massive
data and to retrieve important information from them.
We hope that our recommended methods would provide
some helpful and practical guide in dealing with such big
data. The weakness of the study is the inability to quan-
tify the significance or the relative importance of these
biomarkers. As discussed above, significance testing in the
penalized regression methods remains challenging. Data
mining techniques such as the random forest method
would be useful to evaluate the relative importance of the
biomarkers.
Conclusions
Overall, through simulation studies, penalized linear
regression methods such as SCAD, Adaptive LASSO and
MCP should be considered as plausible alternatives to
traditional stepwise regression. In the PROVIDE study,
selected predictors such as HAZ at week 18, MPO at week
12, and soluble CD14 at week 18 offer a potential expla-
nation for the burden of malnutrition problems in low-
income countries, allow early identification of infants at
risk, and suggest pathways for intervention. Our findings
and suggested methods are not only applicable to the
EE studies, but also to the other biomedical studies for
biomarker selection.
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